nouvelles
les langues
Live Cam
contact
empreinte
Ulm
Français
fr
Deutsch
de
English
en
nouvelles
les langues
Live Cam
contact
empreinte
Français
fr
Deutsch
de
English
en
EKM WS18 Introduction à la médecine clinique
GTE Développement historique de la médecine
Medizin
Button
Robert Koch Institut
Rote Liste
Pub Med
Dolosys
cardiologie
AUG
03
Post-mitotic cardiomyocyte senescence redefines cardiac ageing
By:
Ilias Simon
on
AUG
03
Nature Reviews Cardiology, Published online: 03 August 2026; doi:10.1038/s41569-026-01332-5Ilias Simon and Yohan Santin discuss the study that demonstrated that post-mitotic cardiomyocytes can acquire a senescent phenotype with age.
En savoir plus >>
AUG
03
Social determinants of cardiovascular health: lessons from Whitehall
By:
Benjamin Dowsing
on
AUG
03
Nature Reviews Cardiology, Published online: 03 August 2026; doi:10.1038/s41569-026-01333-4Benjamin Dowsing describes the Whitehall studies, which established the inverse relationship between socioeconomic status and the risk of death from coronary heart disease, leading to the concept of social determinants of health.
En savoir plus >>
JUL
28
Mitochondrial uncoupling therapy reduces established atherosclerosis in mice
By:
Irene Fernández-Ruiz
on
JUL
28
Nature Reviews Cardiology, Published online: 28 July 2026; doi:10.1038/s41569-026-01330-7Targeting systemic metabolism through mild mitochondrial uncoupling with a controlled-release mitochondrial protonophore can reduce atherosclerosis in a mouse model of cardiometabolic syndrome, even when administered at late stages of disease progression.
En savoir plus >>
JUL
27
Cardioprotective properties of empagliflozin and other SGLT2 inhibitors
By:
Thomas A. Zelniker
on
JUL
27
Nature Reviews Cardiology, Published online: 27 July 2026; doi:10.1038/s41569-026-01325-4In this Review, Zelniker and Braunwald summarize the cardioprotective effects of empagliflozin and other sodium–glucose cotransporter 2 inhibitors and discuss the underlying mechanisms of these effects, including haemodynamic modulation, improved mitochondrial bioenergetics and activation of cytoprotective pathways that inhibit oxidative stress, inflammation and fibrosis.
En savoir plus >>
JUL
23
The cardiac 4D nucleome: nuclear and chromatin dynamics across development, disease and ageing
By:
Yinuo Wang
on
JUL
23
Nature Reviews Cardiology, Published online: 23 July 2026; doi:10.1038/s41569-026-01322-7In this Review, Wang and Dobreva discuss nuclear and chromatin organization and remodelling during cardiac development, disease and ageing, highlight emerging methods to investigate nuclear architecture, describe how mechanical and metabolic signals shape the cardiac 4D nucleome, and examine the therapeutic and translational implications for cardiovascular health and disease.
En savoir plus >>
JUL
17
The renaissance of cardiac glycosides in heart failure: why, for whom and when
By:
Antonio Cannata
on
JUL
17
Nature Reviews Cardiology, Published online: 17 July 2026; doi:10.1038/s41569-026-01323-6Cardiac glycosides were the cornerstone of heart failure treatment for decades, but their use progressively declined after the introduction of modern prognostic medications. Two clinical trials now report that cardiac glycosides can reduce the risk of worsening heart failure events in patients with heart failure with reduced ejection fraction. These results do not mandate a paradigm shift but support a specific role for cardiac glycosides in selected patients.
En savoir plus >>
JUL
16
YAP at the heart of cardiac regeneration
By:
Ghulam Mehdi Dar
on
JUL
16
Nature Reviews Cardiology, Published online: 16 July 2026; doi:10.1038/s41569-026-01328-1In this Journal Club article, Dar describes the first study to report the transcriptional coactivator YAP as a central regulator of cardiac regeneration in mice.
En savoir plus >>
JUL
14
In the era of AI, omics and organoids, animal models are still needed in cardiovascular research
By:
Petra Kleinbongard
on
JUL
14
Nature Reviews Cardiology, Published online: 14 July 2026; doi:10.1038/s41569-026-01327-2As artificial intelligence (AI), multiomics and human organoids reshape cardiovascular research, calls to replace animal models are accelerating. We argue that understanding complex, multiorgan cardiovascular disease requires an integrated framework in which in vivo, in vitro and computational models each provide complementary biological insights.
En savoir plus >>
Weitere Beiträge
Oncologie clinique
AUG
04
Benefit from perioperative enfortumab vedotin–pembrolizumab in cisplatin-eligible MIBC
By:
Diana Romero
on
AUG
04
Nature Reviews Clinical Oncology, Published online: 04 August 2026; doi:10.1038/s41571-026-01195-2Benefit from perioperative enfortumab vedotin–pembrolizumab in cisplatin-eligible MIBC
En savoir plus >>
JUL
31
More options, more questions in the management of early relapsed and/or refractory multiple myeloma
By:
Carlyn Rose Tan
on
JUL
31
Nature Reviews Clinical Oncology, Published online: 31 July 2026; doi:10.1038/s41571-026-01191-6In MonumenTAL-3, the G-protein-coupled receptor class C group 5 memberD-directed bispecific T cell engager talquetamab combined with either daratumumab or daratumumab–pomalidomide conferred significantly longer progression-free survival than daratumumab–pomalidomide–dexamethasone in patients with relapsed and/or refractory multiple myeloma (≥1 prior line of therapy). These results herald a new therapeutic option for such patients but also raise questions regarding how talquetamab-based regimens should be integrated with B cell maturation antigen-directed T cell-redirecting therapies.
En savoir plus >>
JUL
30
Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
By:
Solange Peters
on
JUL
30
Nature Reviews Clinical Oncology, Published online: 30 July 2026; doi:10.1038/s41571-026-01188-1With the expanded use of antibody–drug conjugates (ADCs) and immune checkpoint inhibitors (ICIs) in combination, clinicians increasingly face overlapping toxicity profiles with uncertain attribution. The authors of this Review propose a framework that links three interacting layers: immune activation, payload cytotoxicity and payload-independent effects, and provide practical algorithms for evaluation, initial management and treatment resumption in patients receiving ADC monotherapy or ICI–ADC combinations.
En savoir plus >>
JUL
29
De-escalation trials in multiple myeloma: past, present and future
By:
Hira Mian
on
JUL
29
Nature Reviews Clinical Oncology, Published online: 29 July 2026; doi:10.1038/s41571-026-01186-3Current treatment approaches for patients with multiple myeloma are characterized by a ‘more is better’ philosophy aiming for deep and long-term clinical responses. The authors of this Review challenge this paradigm, presenting several de-escalation strategies that do not compromise long-term efficacy and proposing a framework for the design of trials testing further de-escalation approaches.
En savoir plus >>
JUL
28
Electronic cigarettes, smoking and lung cancer risk: some evidence about the continuum of harm
By:
Peter G. Shields
on
JUL
28
Nature Reviews Clinical Oncology, Published online: 28 July 2026; doi:10.1038/s41571-026-01192-5Since the introduction of vaping with electronic cigarettes in the late 2000s, controversy has continued to exist regarding the risks and benefits. Many studies indicate that electronic cigarettes are an effective smoking-cessation tool. Now, a large database analysis by Kim et al. provides a glimpse of the risks of lung cancer for smokers who quit with versus without vaping.
En savoir plus >>
JUL
24
Towards liquid biopsy-based analysis of antitumour immunity
By:
Klaus Pantel
on
JUL
24
Nature Reviews Clinical Oncology, Published online: 24 July 2026; doi:10.1038/s41571-026-01181-8Advances in multimodal analyses of diverse cell types and cellular products present in the blood have presented opportunities to non-invasively and repeatedly assess systemic immune dynamics, predict and monitor responses to immunotherapies, and detect emerging resistance in patients with cancer. In this Review, the authors discuss various insights on systemic antitumour immune responses that can be gleaned through such liquid biopsy-based analysis of circulating tumour-derived biomarkers and/or immune cells and their implications for immunotherapy.
En savoir plus >>
JUL
20
Does OptiTROP-Lung05 open a new frontier for first-line ADC–ICI combinations in NSCLC?
By:
Myung-Ju Ahn
on
JUL
20
Nature Reviews Clinical Oncology, Published online: 20 July 2026; doi:10.1038/s41571-026-01183-6Interim data from the phase III OptiTROP-Lung05 trial demonstrate that adding the TROP2-targeted antibody–drug conjugate sacituzumab tirumotecan to pembrolizumab improves progression-free survival in patients with PD-L1-positive advanced-stage non-small-cell lung cancer. Herein, I present several questions that need to be addressed before this combination can be considered a new standard of care, such as effect on overall survival, long-term safety, global generalizability and biomarker refinement.
En savoir plus >>
JUL
16
Second-line
177
Lu-edotreotide shows promise in GEP NETs
By:
Diana Romero
on
JUL
16
Nature Reviews Clinical Oncology, Published online: 16 July 2026; doi:10.1038/s41571-026-01187-2Second-line 177Lu-edotreotide shows promise in GEP NETs
En savoir plus >>
Weitere Beiträge
endocrinologie
JUL
30
Paracrine signalling in thermogenesis
By:
Claire Greenhill
on
JUL
30
Nature Reviews Endocrinology, Published online: 30 July 2026; doi:10.1038/s41574-026-01292-3Paracrine signalling in thermogenesis
En savoir plus >>
JUL
30
Links between bone fractures and the gut microbiota
By:
Claes Ohlsson
on
JUL
30
Nature Reviews Endocrinology, Published online: 30 July 2026; doi:10.1038/s41574-026-01286-1In this Review, the authors describe evidence linking the gut microbiota to bone fractures. They discuss findings from rodent models and human studies on the effects of the gut microbiota on bone and muscle and explore the mechanisms through which the gut microbiota is associated with bone fractures.
En savoir plus >>
JUL
30
Therapeutic potential of targeting the orexin (hypocretin) system in sleep disorders
By:
Birgitte R. Kornum
on
JUL
30
Nature Reviews Endocrinology, Published online: 30 July 2026; doi:10.1038/s41574-026-01277-2Understanding the key mechanisms underlying sleep and wake states is essential for developing effective treatments for sleep disorders. Here, the authors discuss how the orexin (also known as hypocretin) system — a central regulator of sleep and wakefulness — is a key target in the development of treatments for sleep disorders.
En savoir plus >>
JUL
28
Anti-IL-11 treatment improves ovarian function by reducing matrix stiffness
By:
Olivia Tysoe
on
JUL
28
Nature Reviews Endocrinology, Published online: 28 July 2026; doi:10.1038/s41574-026-01288-zAnti-IL-11 treatment improves ovarian function by reducing matrix stiffness
En savoir plus >>
JUL
28
Local catecholamine catabolism blunts lipolysis in ageing adipose tissue
By:
Fadi Khalaf
on
JUL
28
Nature Reviews Endocrinology, Published online: 28 July 2026; doi:10.1038/s41574-026-01290-5Local catecholamine catabolism blunts lipolysis in ageing adipose tissue
En savoir plus >>
JUL
27
Dose matters: haploinsufficiency in osteogenesis imperfecta
By:
Anastasia Sclocco
on
JUL
27
Nature Reviews Endocrinology, Published online: 27 July 2026; doi:10.1038/s41574-026-01282-5Osteogenesis imperfecta type 1 can be caused by haploinsufficient variants of COL1A1 and can be difficult to diagnose and manage. In this Review, the authors cover the role of collagen type I haploinsufficiency in osteogenesis imperfecta type 1’s pathogenesis, treatment strategies currently under investigation and aspects of this disease that require further research.
En savoir plus >>
JUL
21
Diagnosis, staging and management of obesity: a synthesis of contemporary guidelines
By:
Clara E. Tandar
on
JUL
21
Nature Reviews Endocrinology, Published online: 21 July 2026; doi:10.1038/s41574-026-01279-0Obesity is a chronic, adiposity-based disease with multiple, competing definitions. In the past 2 years, major professional societies have advanced new diagnostic frameworks that incorporate multimodal assessment of adiposity and its clinical consequences. In this Review, Tandar et al. evaluate contemporary anthropometric and body composition measurements, synthesize new frameworks and guidelines for the diagnosis and staging of obesity, and discuss their implications for clinical practice.
En savoir plus >>
JUL
17
Nutrient and non-nutrient regulators of insulin secretion
By:
Jelena Kolic
on
JUL
17
Nature Reviews Endocrinology, Published online: 17 July 2026; doi:10.1038/s41574-026-01281-6This Review explores the regulation of insulin secretion, including the effects of various nutrient and non-nutrient factors. An improved understanding of the complexities of how insulin secretion is regulated could lead to targeted treatments in the future.
En savoir plus >>
Weitere Beiträge
hépatologie
AUG
03
Multidisciplinary Delphi consensus statement on minimal standards for clinical metadata and end points in microbiome studies
By:
Robert Schierwagen
on
AUG
03
Nature Reviews Gastroenterology & Hepatology, Published online: 03 August 2026; doi:10.1038/s41575-026-01229-1In this Consensus Statement, an international panel of experts provides recommendations to harmonize metadata, sampling, analysis and end points in gut microbiome-based clinical research.
En savoir plus >>
JUL
31
Mechanisms, management and prevention of anorectal sexually transmitted infections
By:
Phyu Mon Latt
on
JUL
31
Nature Reviews Gastroenterology & Hepatology, Published online: 31 July 2026; doi:10.1038/s41575-026-01232-6Anorectal bacterial sexually transmitted infections (STIs) remain a global health challenge. This Review provides an overview of anorectal bacterial STIs focusing on chlamydia, gonorrhoea and syphilis, with insights into global burden, pathophysiology, management and prevention, as well as highlighting knowledge gaps and research priorities.
En savoir plus >>
JUL
29
Desynchronization of intestinal circadian clocks and gastrointestinal dysfunction
By:
Yuuki Obata
on
JUL
29
Nature Reviews Gastroenterology & Hepatology, Published online: 29 July 2026; doi:10.1038/s41575-026-01241-5Intestinal circadian clocks are emerging as important regulators of gastrointestinal physiology and homeostasis. Recent advances suggest that desynchronization of circadian clocks in distinct intestinal cell types could contribute to gastrointestinal dysfunction, highlighting new opportunities to understand disease mechanisms and identify future research priorities.
En savoir plus >>
JUL
20
Understanding intrapancreatic fat: charting a path forward
By:
Erica Park
on
JUL
20
Nature Reviews Gastroenterology & Hepatology, Published online: 20 July 2026; doi:10.1038/s41575-026-01234-4Two independent Delphi-driven consensus initiatives have established the first standardized frameworks for defining, measuring and managing intrapancreatic fat. Their areas of agreement provide a foundation for clinical recognition, while key divergences in terminology, thresholds and evidence appraisal highlight critical questions that must be resolved through rigorous collaborative research.
En savoir plus >>
JUL
17
Dupilumab shows promise in eosinophilic gastritis
By:
Eleni Kotsiliti
on
JUL
17
Nature Reviews Gastroenterology & Hepatology, Published online: 17 July 2026; doi:10.1038/s41575-026-01239-zDupilumab shows promise in eosinophilic gastritis
En savoir plus >>
JUL
17
Precision adherence support for hepatitis C treatment
By:
Eleni Kotsiliti
on
JUL
17
Nature Reviews Gastroenterology & Hepatology, Published online: 17 July 2026; doi:10.1038/s41575-026-01238-0Precision adherence support for hepatitis C treatment
En savoir plus >>
JUL
16
PIEZO1 senses the mechanics of liver regeneration
By:
Eleni Kotsiliti
on
JUL
16
Nature Reviews Gastroenterology & Hepatology, Published online: 16 July 2026; doi:10.1038/s41575-026-01237-1PIEZO1 senses the mechanics of liver regeneration
En savoir plus >>
JUL
16
Steatosis fuels replacement liver metastases in colorectal cancer
By:
Eleni Kotsiliti
on
JUL
16
Nature Reviews Gastroenterology & Hepatology, Published online: 16 July 2026; doi:10.1038/s41575-026-01236-2Steatosis fuels replacement liver metastases in colorectal cancer
En savoir plus >>
Weitere Beiträge
néphrologie
JUL
30
Adressing the high burden of kidney disease: lessons from Taiwan
By:
I-Wen Wu
on
JUL
30
Nature Reviews Nephrology, Published online: 30 July 2026; doi:10.1038/s41581-026-01112-xTaiwan carries one of the world’s heaviest kidney disease burdens globally; however, its single-payer universal health-care system has enabled policy-driven transformation of kidney care through population-level screening, multidisciplinary pay-for-performance programmes, data-driven surveillance and digital innovation. These strategies have reduced disease incidence and improved outcomes, and provide a replicable model for health systems elsewhere.
En savoir plus >>
JUL
28
Nephrology care for incarcerated people: a call to action
By:
Laura J. Maursetter
on
JUL
28
Nature Reviews Nephrology, Published online: 28 July 2026; doi:10.1038/s41581-026-01108-7The carceral system has the impossible task of providing appropriate care for a vulnerable population while limiting taxpayer spending. Although many risk factors for incarceration also increase the risk of chronic kidney disease (CKD), specific CKD screening requirements or treatment accountability are lacking, which compromises patient care.
En savoir plus >>
JUL
28
Insights from integrative spatial transcriptomics in sepsis-associated acute kidney injury
By:
Moritz Uhlig
on
JUL
28
Nature Reviews Nephrology, Published online: 28 July 2026; doi:10.1038/s41581-026-01107-8The complexity of the host responses that underlie sepsis-associated acute kidney injury (SA-AKI) complicates patient management and contributes to its high mortality. Here, the authors examine insights into the pathophysiology of SA-AKI gained from the integration of high-resolution spatial transcriptomics with other multi-omics approaches, and consider how these technologies might enable targeted therapeutic interventions.
En savoir plus >>
JUL
28
Epigenetic regulation of kidney development
By:
Samir S. El-Dahr
on
JUL
28
Nature Reviews Nephrology, Published online: 28 July 2026; doi:10.1038/s41581-026-01105-wThis Review describes current understanding of the epigenetic regulation of kidney development. It describes the epigenetic drivers of cell fate decisions made by nephron progenitor cells, the chromatin landscape of accessible regulatory elements that orchestrate these decisions, and the functional consequences for congenital kidney diseases and the programming of adult kidney disease.
En savoir plus >>
JUL
27
WNT organizers control nephron patterning in organoids
By:
Susan J. Allison
on
JUL
27
Nature Reviews Nephrology, Published online: 27 July 2026; doi:10.1038/s41581-026-01113-wWNT organizers control nephron patterning in organoids
En savoir plus >>
JUL
27
The first-in-human combined bladder and kidney transplant
By:
Ellen F. Carney
on
JUL
27
Nature Reviews Nephrology, Published online: 27 July 2026; doi:10.1038/s41581-026-01114-9The first-in-human combined bladder and kidney transplant
En savoir plus >>
JUL
24
Beyond paediatric nephrology: gaps in care for young adults
By:
Michael Rauchman
on
JUL
24
Nature Reviews Nephrology, Published online: 24 July 2026; doi:10.1038/s41581-026-01110-zThe prevalence of kidney disease is increasing in children and young adults, who face a lifetime of chronic disease with considerable morbidity and mortality. However, a critical shortage in the paediatric nephrology workforce and deficiencies in paediatric-to-adult transition care mean that we fail to meet the needs of this vulnerable population. Paediatric and adult nephrologists need to take collaborative action to address this crisis.
En savoir plus >>
JUL
23
Disease modification in lupus nephritis: towards a pathophysiology-based treatment paradigm
By:
Mieke van Schaik
on
JUL
23
Nature Reviews Nephrology, Published online: 23 July 2026; doi:10.1038/s41581-026-01103-yThis Review provides an overview of the pathophysiology of systemic lupus erythematosus as well as drugs that have been developed to target these pathophysiological processes. The authors also synthesize a translational approach aimed at enabling disease modification in lupus nephritis through the integration of glucocorticoids and conventional antiproliferative agents with immunomodulatory drugs.
En savoir plus >>
Weitere Beiträge
neurologie
AUG
04
Losing sleep over glia: new mechanisms for Alzheimer-related sleep disruption
By:
Brendan P. Lucey
on
AUG
04
Nature Reviews Neurology, Published online: 04 August 2026; doi:10.1038/s41582-026-01255-2Sleep disruption in Alzheimer disease has long been viewed as a downstream consequence of amyloid and tau. Two new studies show that glia-mediated mechanisms involving microglia and astrocytic aquaporin 4, rather than amyloid plaque burden, disrupt sleep and are potential targets to prevent Alzheimer disease-related sleep loss.
En savoir plus >>
AUG
03
White matter disorders at the intersection of transcription, RNA processing and translation
By:
Alexandra Chapleau
on
AUG
03
Nature Reviews Neurology, Published online: 03 August 2026; doi:10.1038/s41582-026-01248-1This Review provides a comprehensive overview of white matter disorders, encompassing leukodystrophies and genetically determined leukoencephalopathies, that arise from defects in protein biosynthesis pathways. The authors highlight the role of causal genes across transcription, RNA processing and translation and summarize the clinical and radiological features of these disorders, as well as emerging therapeutic strategies.
En savoir plus >>
AUG
03
Towards a biologically informed description of multiple sclerosis disease course — a roadmap for transition
By:
Alan J. Thompson
on
AUG
03
Nature Reviews Neurology, Published online: 03 August 2026; doi:10.1038/s41582-026-01249-0The current clinical course descriptors of multiple sclerosis do not capture the full disease spectrum or reflect the underlying biological mechanisms. In this Roadmap, the International Advisory Committee on Clinical Trials in Multiple Sclerosis proposes a roadmap for transitioning towards biologically informed descriptors of the multiple sclerosis disease course.
En savoir plus >>
JUL
29
Low-field MRI for equitable epilepsy diagnosis in resource-limited settings
By:
Melody T. Asukile
on
JUL
29
Nature Reviews Neurology, Published online: 29 July 2026; doi:10.1038/s41582-026-01252-5Low-field MRI for equitable epilepsy diagnosis in resource-limited settings
En savoir plus >>
JUL
29
Reply to ‘Low-field MRI for equitable epilepsy diagnosis in resource-limited settings’
By:
Tavia E. Evans
on
JUL
29
Nature Reviews Neurology, Published online: 29 July 2026; doi:10.1038/s41582-026-01253-4Reply to ‘Low-field MRI for equitable epilepsy diagnosis in resource-limited settings’
En savoir plus >>
JUL
28
Newborn screening is the missing step in spinal muscular atrophy care
By:
Jesy Nelson
on
JUL
28
Nature Reviews Neurology, Published online: 28 July 2026; doi:10.1038/s41582-026-01250-7Disease-modifying therapies for spinal muscular atrophy have transformed the disease prognosis, yet many children continue to face substantial disability owing to delayed diagnosis. Rapid implementation of newborn screening is imperative to offer life-changing interventions for affected families.
En savoir plus >>
JUL
16
Brain-first and body-first subtypes of Lewy body disease
By:
Per Borghammer
on
JUL
16
Nature Reviews Neurology, Published online: 16 July 2026; doi:10.1038/s41582-026-01241-8The brain-first versus body-first model proposes that Lewy body disease can originate from different pathogenic routes, accounting for heterogeneity in symptoms, neurodegeneration patterns and post-mortem pathology. Here, Borghammer et al. evaluate the evidence for this model, outline its implications for diagnosis, therapy and prevention, and identify priorities for future research.
En savoir plus >>
JUL
14
Neurological symptoms in survivors of Ebola virus disease
By:
Lisa Kiani
on
JUL
14
Nature Reviews Neurology, Published online: 14 July 2026; doi:10.1038/s41582-026-01247-2Ebola virus disease is associated with a broad range of long-term neurological sequalae, a new study reports.
En savoir plus >>
Weitere Beiträge
rhumatologie
AUG
04
Navigating evidence-based recommendations for the management of systemic sclerosis
By:
Francesco Del Galdo
on
AUG
04
Nature Reviews Rheumatology, Published online: 04 August 2026; doi:10.1038/s41584-026-01416-zIn this Review article, the authors compare current guidelines for systemic sclerosis, including recommendations for systemic sclerosis-associated interstitial lung disease. They emphasize the importance of alignment across guidelines to support informed clinical decision-making and patient care.
En savoir plus >>
AUG
04
Advances in the treatment of eosinophilic granulomatosis with polyangiitis
By:
Adrien Cottu
on
AUG
04
Nature Reviews Rheumatology, Published online: 04 August 2026; doi:10.1038/s41584-026-01406-1The development of targeted therapeutics has transformed the management of eosinophilic granulomatosis with polyangiitis (EGPA). This Review explores the role of these new therapies, as well as that of the still-relevant historical treatments, for the induction and maintenance of remission in EGPA.
En savoir plus >>
AUG
03
When less is more: loss of IRAK2 signalling promotes inflammation
By:
Adriana A. de Jesus
on
AUG
03
Nature Reviews Rheumatology, Published online: 03 August 2026; doi:10.1038/s41584-026-01414-1The identification of IRAK2 deficiency reveals how impaired Myddosome signalling can paradoxically promote interferon-driven inflammation, which expands the spectrum of monogenic immune dysregulation and underscores the importance of detecting structural variants in unsolved inborn errors of immunity.
En savoir plus >>
AUG
03
Metabolic exhaustion and immune ageing in rheumatoid arthritis
By:
Cornelia M. Weyand
on
AUG
03
Nature Reviews Rheumatology, Published online: 03 August 2026; doi:10.1038/s41584-026-01402-5This Review examines how ageing-driven metabolic exhaustion in T cells and macrophages promotes organelle dysfunction, inflammatory cell death and chronic synovitis in rheumatoid arthritis.
En savoir plus >>
AUG
03
Sex-dependent mechanisms in rheumatic diseases
By:
Elizabeth R. Volkmann
on
AUG
03
Nature Reviews Rheumatology, Published online: 03 August 2026; doi:10.1038/s41584-026-01405-2Sex-dependent mechanisms, including sex hormones, X chromosome biology, epigenetic regulation, microbiome dynamics and antiviral immunity, interact to shape immune responses and contribute to differences in susceptibility, manifestations and treatment outcomes in rheumatic diseases, highlighting opportunities for precision, sex-informed therapeutic strategies.
En savoir plus >>
JUL
31
Controlled release of magnesium ions shapes osteoporotic bone repair
By:
Sarah Onuora
on
JUL
31
Nature Reviews Rheumatology, Published online: 31 July 2026; doi:10.1038/s41584-026-01418-xAn osteoimmunomodulatory implant that enables finely tuned release of magnesium ions could offer a way to enhance osteoporotic bone repair.
En savoir plus >>
JUL
31
From psoriatic plaque to synovium: decoding the skin–joint axis in psoriatic arthritis
By:
Maria Gabriella Raimondo
on
JUL
31
Nature Reviews Rheumatology, Published online: 31 July 2026; doi:10.1038/s41584-026-01412-3This Review synthesizes evidence for a skin–joint axis in psoriatic arthritis (PsA), highlighting key mechanisms that might drive the transition from psoriasis to PsA. The authors emphasize that further research into this axis could be important for identifying biomarkers, informing patient stratification and predicting which patients will progress to PsA.
En savoir plus >>
JUL
30
PD-1 agonism puts the brakes on pathogenic T cell responses in RA
By:
Holly Webster
on
JUL
30
Nature Reviews Rheumatology, Published online: 30 July 2026; doi:10.1038/s41584-026-01417-yPD-L2-mediated activation of PD-1 signalling in rheumatoid arthritis suppresses pro-inflammatory cytokine production and regulates pathogenic B cell responses.
En savoir plus >>
Weitere Beiträge
urologie
AUG
03
Beyond surgical technique: modifiable risk factors and evolving treatment paradigms in bladder cancer surgery
By:
Pietro Scilipoti
on
AUG
03
Nature Reviews Urology, Published online: 03 August 2026; doi:10.1038/s41585-026-01180-5Beyond surgical technique: modifiable risk factors and evolving treatment paradigms in bladder cancer surgery
En savoir plus >>
AUG
03
Routine testosterone screening in military personnel: an opportunity for evidence-based implementation in men’s health
By:
Mohamed Mubarak
on
AUG
03
Nature Reviews Urology, Published online: 03 August 2026; doi:10.1038/s41585-026-01181-4The US military’s proposal for routine testosterone screening presents a unique opportunity to improve men’s health. However, translating policy into practice will require evidence-based screening, accurate diagnosis, appropriate patient selection and careful consideration of fertility, lifestyle factors and long-term monitoring.
En savoir plus >>
JUL
27
The urinary microbiome, overactive bladder and bladder pain syndrome/interstitial cystitis — mechanisms, diagnostics and therapeutic opportunities
By:
Martina Spazzapan
on
JUL
27
Nature Reviews Urology, Published online: 27 July 2026; doi:10.1038/s41585-026-01174-3This Review synthesizes current evidence on the urinary microbiome in overactive bladder and bladder pain syndrome/interstitial cystitis, focusing on translational relevance. The authors discussed mechanistic links to symptoms and emerging interventions. Integration into clinical practice is also discussed, highlighting crucial gaps in causality, biomarkers and therapeutic targeting.
En savoir plus >>
JUL
21
Mohs micrographic surgery and reconstruction for glans and urethral squamous cell carcinoma
By:
Grant Sprow
on
JUL
21
Nature Reviews Urology, Published online: 21 July 2026; doi:10.1038/s41585-026-01176-1Mohs micrographic surgery offers a tissue-sparing alternative to penectomy for penile squamous cell carcinoma involving the glans and distal urethra, yet technical guidance remains scarce. We detail the surgical approach, specimen handling and reconstruction strategies to help surgeons navigate this challenging procedure and improve patient access to organ-preserving care.
En savoir plus >>
JUL
20
Extending a pleasure-based paradigm: reflections on male-centred assumptions in sexual medicine
By:
Sam Geuens
on
JUL
20
Nature Reviews Urology, Published online: 20 July 2026; doi:10.1038/s41585-026-01175-2Extending a pleasure-based paradigm: reflections on male-centred assumptions in sexual medicine
En savoir plus >>
JUL
20
Escaping the matrix: disrupted integrin signalling enables neuroendocrine differentiation
By:
Jacob Egelberg
on
JUL
20
Nature Reviews Urology, Published online: 20 July 2026; doi:10.1038/s41585-026-01177-0Escaping the matrix: disrupted integrin signalling enables neuroendocrine differentiation
En savoir plus >>
JUL
09
Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer
By:
Sean A. Fletcher
on
JUL
09
Nature Reviews Urology, Published online: 09 July 2026; doi:10.1038/s41585-026-01172-5This Review provides an overview of currently available intraprostatic immunotherapy approaches, discussing rationale, main strategies, results from early-phase trials and the current limitations associated with this approach. The authors also discuss future perspectives regarding clinical implementation, describing opportunities and challenges.
En savoir plus >>
JUL
01
Untangling the anterolateral periprostatic neurovasculature and its implications for nerve-sparing radical prostatectomy
By:
Behnam Nabavizadeh
on
JUL
01
Nature Reviews Urology, Published online: 01 July 2026; doi:10.1038/s41585-026-01169-0Several studies have demonstrated that a posterior approach to nerve sparing by preserving more anterolateral periprostatic tissue can improve erectile function by more than twofold. Review of the evidence regarding periprostatic nerve distribution suggests a potential underappreciation of the distribution and functional relevance of nerve fibres along the anterior prostate.
En savoir plus >>
Weitere Beiträge
Partager
Tweet
Partager
Courrier
La version française de ce site est principalement traduite automatiquement par "google translate". En cas de difficultés linguistiques, n'hésitez pas à me contacter.
Share by: